SARS-CoV-2 viral load dynamics in immunocompromised critically ill patients on remdesivir treatment

The relationship between SARS-CoV-2 quantitative viral load and risk of disease progression, morbidity such as long- COVID or mortality in immunosuppressed, remains largely undefined in COVID-19 patients. Critically ill immunosuppressed patients potentially benefit from remdesivir treatment because...

Descripción completa

Detalles Bibliográficos
Autores principales: Lahmer, Tobias, Erber, Johanna, Schmid, Roland M., Schneider, Jochen, Spinner, Christoph D., Luppa, Peter, Sörgel, Fritz, Kinzig, Martina, Rasch, Sebastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2022
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134301/
https://www.ncbi.nlm.nih.gov/pubmed/35646346
http://dx.doi.org/10.4081/mrm.2022.825

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9134301/
https://www.ncbi.nlm.nih.gov/pubmed/35646346
http://dx.doi.org/10.4081/mrm.2022.825

Ejemplares similares